Apple Inc. (AAPL) has introduced a redesigned Blood Oxygen feature for Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 users through updates to iOS (18.6.1) and watchOS (11.6.1). This update is aimed at enhancing the health tracking capabilities of the devices and is expected to drive sales in the Wearables, Home, and Accessories category.
Sales in this category decreased by 8.6% year over year to $7.4 billion, making up 7.9% of net sales in Q3 fiscal 2025, although this figure exceeded market expectations by 0.85%. The Zacks Consensus Estimate for future sales in this category is forecasted at $8.32 billion, indicating another 8% decline compared to last year.
Despite being a leader in the wearables market, Apple faces competition from companies like Garmin and Alphabet (GOOGL), which are enhancing their offerings with new health features and functionalities. Apple shares have declined by 7.8% year to date, contrasting with a 13.9% gain in the broader Zacks Computer and Technology sector.
